MetLife Investment Management’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$98.2K Hold
23,773
﹤0.01% 2781
2026
Q1
$85.8K Buy
+23,773
New +$82.2K ﹤0.01% 2602
2025
Q4
Sell
-22,631
Closed -$154K 2847
2025
Q3
$154K Hold
22,631
﹤0.01% 2457
2025
Q2
$308K Buy
22,631
+1,806
+9% +$17.1K ﹤0.01% 1943
2025
Q1
$113K Sell
20,825
-313
-1% -$1.78K ﹤0.01% 2470
2024
Q4
$105K Hold
21,138
﹤0.01% 2601
2024
Q3
$111K Buy
21,138
+11,910
+129% +$68.7K ﹤0.01% 2583
2024
Q2
$63.3K Buy
+9,228
New +$84.4K ﹤0.01% 2722

Other funds holding LFMD

MetLife Investment Management's LFMD Position: Q2 2026 in Review

MetLife Investment Management held its LifeMD (LFMD) position steady in Q2 2026 at 23,773 shares worth $98.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2781.

MetLife Investment Management first reported a position in LFMD in Q2 2024 and has held it in 8 quarters since. The position peaked at $308K in Q2 2025. 116 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • MetLife Investment Management held 23,773 shares of LifeMD worth $98.2K as of Q2 2026.
  • MetLife Investment Management left its LifeMD share count unchanged in Q2 2026.
  • LifeMD made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2781 holding.
  • MetLife Investment Management first reported a position in LifeMD in Q2 2024 and has held it in 8 quarters since.
  • MetLife Investment Management's LifeMD position peaked at $308K in Q2 2025.
  • 116 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.